Distribuzione geografica
Continente #
EU - Europa 9.845
Totale 9.845
Nazione #
IT - Italia 9.845
Totale 9.845
Città #
Genova 7.233
Rapallo 1.590
Genoa 964
Bordighera 58
Totale 9.845
Nome #
Visual Versus Semi-Quantitative Analysis of 18F-FDG-PET in Amnestic MCI: An European Alzheimer's Disease Consortium (EADC) Project. 161
Brain 18F-DOPA PET and cognition in de novo Parkinson's disease. 144
A normative study of the Italian printed word version of the free and cued selective reminding test 141
Alzheimer’s disease markers from structural MRI and FDG-PET brain images 139
Brain Functional Network in Alzheimer’s Disease: Diagnostic Markers for Diagnosis and Monitoring 130
Assessment of cognitive profile as a prodromal marker of the evolution of REM sleep Behavior Disorder 128
Radionuclide brain imaging correlates of cognitive impairment in Parkinson's disease (PD). 126
Neuroimaging findings in mild cognitive impairment 124
Brain perfusion correlates of cognitive and nigrostriatal functions in de novo Parkinson's disease. 123
How legislation on decisional capacity can negatively affect the feasibility of clinical trials in patients with dementia. 122
Analysis of video-polysomnographic sleep findings in dementia with Lewy bodies. 120
Nigro-caudate dopaminergic deafferentation: A marker of REM sleep behavior disorder? 118
Head-to-Head Comparison among Semi-Quantification Tools of Brain FDG-PET to Aid the Diagnosis of Prodromal Alzheimer's Disease 117
Functional neuroimaging and clinical features of drug naive patients with de novo Parkinson's disease and probable RBD 115
Prediction of cognitive worsening in de novo Parkinson's disease: Clinical use of biomarkers 115
What predicts cognitive decline in de novo Parkinson's disease? 114
Brain perfusion SPECT provides new insight on neurobiological effects of hyperbaric hyperoxia. 112
Cognitive-nigrostriatal relationships in de novo, drug-naïve Parkinson's disease patients: a [I-123]FP-CIT SPECT study. 110
The role of the serotonergic system in REM sleep behavior disorder 110
Does postural rigidity decrease during REM sleep without Atonia in Parkinson disease? 110
Volume of interest-based [(18)F]fluorodeoxyglucose PET discriminates MCI converting to Alzheimer's disease from healthy controls. A European Alzheimer's Disease Consortium (EADC) study. 108
Striatal dopamine transporter SPECT quantification: head-to-head comparison between two three-dimensional automatic tools 108
Mapping brain morphological and functional conversion patterns in predementia late-onset bvFTD 107
Neuroimaging features in C9orf72 and TARDBP double mutation with FTD phenotype. 107
Abnormalities of cortical neural synchronization mechanisms in patients with dementia due to Alzheimer's and Lewy body diseases: an EEG study 107
Parkinson’s Disease Sleep Scale 2: application in an Italian population 106
Correlation between Doppler velocities and duplex ultrasound carotid cross-sectional percent stenosis. 105
Seizures can precede cognitive symptoms in late-onset Alzheimer's disease. 105
Abnormalities of resting-state functional cortical connectivity in patients with dementia due to Alzheimer's and Lewy body diseases: an EEG study 105
Plasma antioxidants and brain glucose metabolism in elderly subjects with cognitive complaints. 104
The clinical relevance of cognitive impairment in REM sleep behavior disorder 103
Early identification of MCI converting to AD: a FDG PET study 102
The Alzheimer's disease metabolic brain pattern in mild cognitive impairment 102
Idiopathic REM sleep behavior disorder and neurodegenerative risk: To tell or not to tell to the patient? How to minimize the risk? 101
Integrating Sleep and Alzheimer's Disease Pathophysiology: Hints for Sleep Disorders Management 101
Accuracy and generalization capability of an automatic method for the detection of typical brain hypometabolism in prodromal Alzheimer disease 101
Seven tesla MRI of the substantia nigra in patients with rapid eye movement sleep behavior disorder 100
Abnormalities of Resting State Cortical EEG Rhythms in Subjects with Mild Cognitive Impairment Due to Alzheimer's and Lewy Body Diseases 100
Cortical Network Topology in Prodromal and Mild Dementia Due to Alzheimer’s Disease: Graph Theory Applied to Resting State EEG 100
New tracers and new perspectives for molecular imaging in Lewy body diseases 100
Frontal Variant Alzheimer Disease or Frontotemporal Lobe Degeneration With Incidental Amyloidosis? 95
Loss of REM sleep features across nighttime in REM sleep behavior disorder 95
Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study 95
Presynaptic dopaminergic neuroimaging in REM sleep behavior disorder: A systematic review and meta-analysis 92
Functional imaging in pre-motor Parkinson's disease 91
Functional cortical source connectivity of resting state electroencephalographic alpha rhythms shows similar abnormalities in patients with mild cognitive impairment due to Alzheimer's and Parkinson's diseases 91
Progressive disgregation of brain networking from normal aging to Alzhimer's Disease. Independent Component Analysis on FDG-PET data 89
Neuroimaging findings and clinical trajectories of Lewy body disease in patients with MCI 88
The influence of nigrostriatal dopaminergic dysfunction on cognition of de novo Parkinson's disease patients 87
The prognostic value of sleep patterns in disorders of consciousness in the sub-acute phase 87
Abnormal pattern of brain glucose metabolism in Parkinson's disease: replication in three European cohorts 86
Dopaminergic imaging and clinical predictors for phenoconversion of REM sleep behaviour disorder 86
Abnormalities of functional cortical source connectivity of resting-state electroencephalographic alpha rhythms are similar in patients with mild cognitive impairment due to Alzheimer's and Lewy body diseases 84
Brain glucose metabolism heterogeneity in idiopathic REM sleep behavior disorder and in Parkinson's disease 83
What predicts future cognitive decline in de novo Parkinson’s disease (PD)? 82
Neurophysiological Assessment of Alzheimer's Disease Individuals by a Single Electroencephalographic Marker 82
Is dopamine transporter invariably impaired at the time of diagnosis in dementia with Lewy bodies? 82
The pharmacotherapeutic management of obstructive sleep apnea 81
The fate of patients with REM sleep behavior disorder and Mild Cognitive Impairment 81
Direct correlation between cardiac and striatal F-18-DOPA uptake in de novo Parkinson's disease 80
Metabolic patterns across core features in dementia with lewy bodies 80
A kinetics-based approach to amyloid PET semi-quantification 80
Metabolic correlates of rey auditory verbal learning test in elderly subjects with memory complaints 80
Levodopa may affect cortical excitability in Parkinson's disease patients with cognitive deficits as revealed by reduced activity of cortical sources of resting state electroencephalographic rhythms 79
Predicting the transition from normal aging to Alzheimer's disease: A statistical mechanistic evaluation of FDG-PET data 78
Abnormalities of Cortical Neural Synchronization Mechanisms in Subjects with Mild Cognitive Impairment due to Alzheimer's and Parkinson's Diseases: An EEG Study 77
Brain dopaminergic correlates of cognitive functions in de novo parkinson’s disease: a 18FDOPA PET study. 76
Abnormalities of resting-state EEG in patients with prodromal and overt dementia with Lewy bodies: Relation to clinical symptoms 75
Getting the high school diploma with only one hemisphere: a case report 74
Metabolic correlates of dopaminergic loss in dementia with lewy bodies 73
Added value of semiquantitative analysis of brain FDG-PET for the differentiation between MCI-Lewy bodies and MCI due to Alzheimer’s disease 73
Recommendations of the Sleep Study Group of the Italian Dementia Research Association (SINDem) on clinical assessment and management of sleep disorders in individuals with mild cognitive impairment and dementia: a clinical review. 72
Performance of [18F] FDG-PET in 142 MCI patients with at least 2 years clinical follow up: a multicentric study of the European Alzheimer Disease Consortium (EADC) 72
18F–FDG PET diagnostic and prognostic patterns do not overlap in Alzheimer’s disease (AD) patients at the mild cognitive impairment (MCI) stage 72
Comparative study of MRI biomarkers in the substantia nigra to discriminate idiopathic Parkinson disease 72
Brain Resources: How Semantic Cueing Works in Mild Cognitive Impairment due to Alzheimer’s Disease (MCI-AD) 71
null 70
Metabolic correlates of reserve and resilience in MCI due to Alzheimer's Disease (AD) Rik Ossenkoppele 70
Scaled Subprofile Modeling and Convolutional Neural Networks for the Identification of Parkinson's Disease in 3D Nuclear Imaging Data 69
Cognitive impairment in degenerative parkinsonisms: role of radionuclide brain imaging. 68
null 67
123I-FP-CIT SPECT validation of nigro-putaminal MRI tractography in dementia with Lewy bodies 67
null 66
Neuroimaging Findings in Mild Cognitive Impairment 64
Abnormalities of Cortical Sources of Resting State Alpha Electroencephalographic Rhythms are Related to Education Attainment in Cognitively Unimpaired Seniors and Patients with Alzheimer's Disease and Amnesic Mild Cognitive Impairment 64
Dopaminergic Activity and Cognitive Function in de novo Parkinson Disease patients: an 18F-DOPA PET/CT study 63
Lupus nephritis and Cyclic Vomiting Syndrome: a case report. 62
Resting metabolic connectivity in Alzheimer's disease 60
The role of anterior prefrontal cortex in prospective memory: an exploratory FDG-PET study in early Alzheimer's disease 60
Associations among education, age, and the dementia with Lewy bodies (DLB) metabolic pattern: A European-DLB consortium project 60
Hyperconnectivity in Dementia Is Early and Focal and Wanes with Progression 59
Metabolic network abnormalities in drug-naïve Parkinson's Disease 57
Nigrocaudate dopaminergic impairment predict future cognitive decline in de novo parkinson’s disease (PD) 57
Probing the Role of a Regional Quantitative Assessment of Amyloid PET 57
Abnormal cortical neural synchronization mechanisms in quiet wakefulness are related to motor deficits, cognitive symptoms, and visual hallucinations in Parkinson's disease patients: an electroencephalographic study 56
Anatomical and neurochemical bases of theory of mind in de novo Parkinson's Disease 56
Epilepsy course during COVID-19 pandemic in three Italian epilepsy centers 55
Neuroimaging of Rapid Eye Movement Sleep Behavior Disorder 54
Multicenter Study on Sleep and Circadian Alterations as Objective Markers of Mild Cognitive Impairment and Alzheimer's Disease Reveals Sex Differences 54
Utility of quantitative EEG in early Lewy body disease 53
Totale 8.960
Categoria #
all - tutte 32.910
article - articoli 30.835
book - libri 0
conference - conferenze 1.220
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 855
Totale 65.820

Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019497 0 0 0 0 0 0 0 0 9 101 211 176
2019/20202.683 95 63 78 165 228 286 399 275 293 451 277 73
2020/20211.462 70 129 96 200 134 146 131 123 83 168 89 93
2021/20221.577 49 52 120 153 57 128 68 334 124 186 77 229
2022/20231.845 138 151 38 195 224 251 9 232 309 53 209 36
2023/2024837 67 98 30 176 101 196 86 81 2 0 0 0
Totale 10.226